
Share on:
Arcam acquired its strategic contract manufacturing partner, DiSanto Technology, for US $15.8MM in cash and stock. For the last 12 months, DiSanto generated revenue of ~$12MM. DiSanto will become a subsidiary of Arcam and will continue operations under its existing management. (Source: Arcam)
RELATED ARTICLES
4D Medicine to Showcase Breakthrough Biomaterials at OMTEC 2025
Jun 06 2025 , Julie A. Vetalice
Placon Announces New Costa Rica Warehouse and Distribution Facility
Jun 02 2025 , Julie A. Vetalice
On a Mission to Create Equity in Worldwide Orthopedic Care
May 28 2025 , BONEZONE Editors